The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...

The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.

Research on tropical health is a critical field that addresses both infectious and non-infectious diseases prevalent in ...

The murder of a US Border Patrol agent near the Canadian border appears to be linked to a radical leftist trans militant cult ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the progress of the U.S. commercial launch of Ryoncil ® ...

DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial ...

Some Kentucky hemp are questioning the legitimacy of how some medical cannabis cultivators got picked and the state auditor could be investigating the process.

Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.

Leprosy, an ancient disease caused by Mycobacterium leprae, continues to pose significant public health challenges, ...

In a market already saturated with oil, companies aren't likely to drill more. But the oil and gas industry still stands to ...